NAGE Stock: Niagen Bioscience Inc Stock Price, Analysis & Insights
Get live NAGE stock price $3.51, comprehensive Niagen Bioscience Inc stock analysis, charts, news, and expert forecast. Real-time NAGE stock data and investment insights.
Loading chart data...
Niagen Bioscience Inc (NAGE) Overview
Niagen Bioscience Inc (NAGE) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, NAGE trades at $3.51 with a market capitalization of 279.85M . Over the past 52 weeks, NAGE has traded between $3.35 and $14.69 , with the current price positioned at approximately 1% of this range . The stock currently trades at...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 279.85M
- Current price: $3.51
- 52-week range: $3.35 - $14.69
- P/E ratio: 16.73
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Company Information
- CEO
- Robert N. Fried
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 104
Contact Information
- Address
- 10900 Wilshire Blvd, Suite 600
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.7)
✓ Higher growth potential with elevated volatility (Beta: 2.06)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Niagen Bioscience Inc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Niagen Bioscience Inc
- ⚠Investors should consider how Niagen Bioscience Inc fits within their overall portfolio allocation
Market Cap
279.85M
P/E Ratio (TTM)
16.73
Beta
2.06
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NAGE with peer companies:
- Price
- $0.86
- Market cap
- 231.72M
- Price
- $11.43
- Market cap
- 960.77M
- Price
- $27.00
- Market cap
- 1.44B
- Price
- $10.05
- Market cap
- 321.65M
- Price
- $9.90
- Market cap
- 864.74M
- Price
- $8.15
- Market cap
- 426.42M
- Price
- $6.15
- Market cap
- 317.68M
- Price
- $31.13
- Market cap
- 575.99M
- Price
- $14.00
- Market cap
- 1.00B
- Price
- $13.57
- Market cap
- 802.19M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.